Lifeline for kids: expanded access to vedolizumab for severe IBD
NCT ID NCT06856135
First seen Mar 02, 2026 · Last updated May 15, 2026 · Updated 15 times
Summary
This program offers continued access to vedolizumab, given as an IV infusion, for children and teenagers with moderate to severe ulcerative colitis or Crohn's disease who completed a prior study and still benefit from the treatment. It is designed for those without suitable alternatives in the U.S. until the drug becomes commercially available. The goal is to maintain disease control and prevent worsening symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Center for Digestive Healthcare
AVAILABLEAtlanta, Georgia, 30342, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Seattle Children's Hospital
AVAILABLESeattle, Washington, 98105, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of California San Francisco
AVAILABLESan Francisco, California, 94158, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.